p38-MAPK and CDK5, signaling pathways in neuroinflammation: a potential therapeutic intervention in Alzheimer's disease?
Main Authors: | Vlad Ionut Viorel, Ylenia Pastorello, Nosherwan Bajwa, Mark Slevin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=8;spage=1649;epage=1650;aulast=Viorel |
Similar Items
-
Micro-Fragmented Adipose Tissue as a Natural Scaffold for Targeted Drug Delivery in Brain Cancer
by: Alex Salagean, et al.
Published: (2023-07-01) -
Mesenchymal stem cell stroke therapy: current limitations in its clinical translation
by: Ylenia Pastorello, et al.
Published: (2023-06-01) -
p38MAPK Signaling Pathway in Osteoarthritis: Pathological and Therapeutic Aspects
by: Li Z, et al.
Published: (2022-02-01) -
A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia
by: Joseph Cooper, et al.
Published: (2023-01-01) -
Monomeric C-reactive protein: a link between chronic inflammation and neurodegeneration?
by: Nicoleta Arnaut, et al.
Published: (2024-01-01)